ACYCLOVIR
Generic: ACYCLOVIR
ACYCLOVIR is FDA application ANDA212173, sponsored by YILING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actual
Labeling: Incorrect or Missing Lot and/or Exp Date
Crystallization: customer complaints for crystallization in finished product.
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemi
Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile
Crystallization: customer complaints for crystallization in finished product.
Presence of Foreign Substance: human hair melded into tablet.
Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate float